Poster Session 3.H - Pharmaceutical Sciences and Health Technologies
Dr. Csík, Boglárka
CNNG6W
Faculty of Medicine, Semmelweis University, Institute of Preventive Medicine and Public Health, Budapest, Hungary
+36304930480
csik.boglarka@semmelweis.hu
Novel Engineered Fusogenic Liposome-Based Antioxidant Delivery Improves Blood–Brain Barrier Integrity in Aging
Dr. Csík Boglárka1,2,3, Shanmugarama Santny2,3, Gronemann Till4, Dr. Patai Roland2,3, Dr. Nyúl-Tóth Ádám2,3, Dr. Ungvári Zoltán2,3,5
1: Semmelweis University, Health Sciences Program, Doctoral College, Budapest, Hungary
2: University Of Oklahoma Health Sciences Center, Department of Neurosurgery, Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Oklahoma City, United States
3: University Of Oklahoma Health Sciences Center, Oklahoma Center for Geroscience and Healthy Brain Aging, Oklahoma City, United States
4: Forschungszentrum Jülich GmbH, Institute of Biological Information Processing: Mechanobiology (IBI-2), Jülich, Germany
5: Faculty of Medicine, Semmelweis University, Institute of Preventive Medicine and Public Health, Budapest, Hungary
Poszter
Poster Session 3.H - Pharmaceutical Sciences and Health Technologies
English
Pharmaceutical Sciences and Health Technologies
Introduction: Vascular defects contribute to age-related neurodegeneration and cognitive impairment. Blood–brain barrier (BBB) breakdown and neurovascular uncoupling lead to cerebral blood flow deficits, neuroinflammation, and decreased cognitive function. The naturally occurring polyphenol resveratrol (RSV) attenuates oxidative stress, thus improving vascular health. However, its oral bioavailability is low; therefore, it requires an alternative delivery system to enhance the efficiency of antioxidant and anti-inflammatory polyphenols.
Aims: We introduced a novel fusogenic liposomal (FL) system with an engineered apolipoprotein E (ApoE)-based protein corona to enhance RSV bioavailability and directly target cerebrovascular endothelial cells, thereby increasing RSV uptake and improving delivery to protect the cerebral microvasculature during aging. Our central hypothesis was that endothelial barrier dysfunction can be reduced by ApoE-FLs loaded with RSV, thus mitigating vascular cognitive dysfunction.
Methods: Biodistribution of fluorescently labeled FL and ApoE-FL was assessed ex vivo in multiple organs following in vivo administration. Organs were collected, processed into histological sections, imaged using confocal microscopy, and analyzed with quantitative image analysis. In vivo multiphoton imaging was used to assess the BBB longitudinally, and the radial arm water maze was used to assess cognition.
Results: ApoE-FL-RSV showed significantly greater accumulation in brain endothelial cells in vivo compared to non-targeted FLs. In aged mice, both FL and ApoE-FL treatment improved BBB integrity and cognition.
Conclusion: Targeted delivery of RSV via ApoE-FL improves cerebrovascular function and mitigates cognitive decline in aging, representing a promising therapeutic strategy against age-related vascular impairment and cognitive decline.
Funding: EKÖP-2025-703, University Research Scholarship Programme of the Ministry of Culture and Innovation from the source of the National Research, Development and Innovation Fund, American Heart Association (ANT: AHA834339), National Institute on Aging (RF1AG072295, R01AG055395, R01AG068295; R01AG070915, K01AG073614), the National Institute of Neurological Disorders and Stroke (R01NS100782)
Semmelweis University
Prof. Dr. Ungvári Zoltán
I do not give consent to the publication of my abstract on the website of the congress.
in doctoral studies after complex exam (PhD)
Szabad
elfogadva
poszter
nem rendelkezett róla
8945
14:12
14:15